Bacillus licheniformis BlaR1 L3 Loop Is a Zinc Metalloprotease Activated by Self-Proteolysis by Berzigotti, Stéphanie et al.
Bacillus licheniformis BlaR1 L3 Loop Is a Zinc
Metalloprotease Activated by Self-Proteolysis
Ste ´phanie Berzigotti
., Kamal Benlafya
.,J e ´re ´my Se ´pulchre, Ana Amoroso, Bernard Joris*
Centre for Protein Engineering, Department of Life Sciences, University of Lie `ge, Lie `ge, Belgium
Abstract
In Bacillus licheniformis 749/I, BlaP b-lactamase is induced by the presence of a b-lactam antibiotic outside the cell. The first
step in the induction mechanism is the detection of the antibiotic by the membrane-bound penicillin receptor BlaR1 that is
composed of two functional domains: a carboxy-terminal domain exposed outside the cell, which acts as a penicillin sensor,
and an amino-terminal domain anchored to the cytoplasmic membrane, which works as a transducer-transmitter. The
acylation of BlaR1 sensor domain by the antibiotic generates an intramolecular signal that leads to the activation of the L3
cytoplasmic loop of the transmitter by a single-point cleavage. The exact mechanism of L3 activation and the nature of the
secondary cytoplasmic signal launched by the activated transmitter remain unknown. However, these two events seem to
be linked to the presence of a HEXXH zinc binding motif of neutral zinc metallopeptidases. By different experimental
approaches, we demonstrated that the L3 loop binds zinc ion, belongs to Gluzincin metallopeptidase superfamily and is
activated by self-proteolysis.
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Introduction
During evolution, the most common resistance mechanism
acquired by eubacteria to resist b-lactam antibiotic action is the
production of a b-lactamase that degrades these antibiotics by
opening their b-lactam ring [1,2]. The cleaved antibiotic is then
unable to acylate its membrane-bound D,D-peptidase targets,
which are involved in the peptidoglycan cross-linking or remod-
eling. These enzymes inhibited by b-lactam antibiotics are named
penicillin-binding proteins (PBPs).
In Bacillus licheniformis and Staphylococcus aureus, the production of
an inducible class A b-lactamase, BlaP and BlaZ respectively, is
regulated by the BlaI repressor that maintains b-lactamase
production at a low level in the absence of a b-lactam antibiotic
outside the cell. In presence of a b-lactam antibiotic at sublethal
concentration, the BlaI repressor is inactivated by a protein relay
including the membrane-bound penicillin-sensory transducer
BlaR1 and the BlaR2 protein, yet to be identified [3,4,5]. The
regulatory genes, blaI and blaR1 are located downstream the blaP/
blaZ genes and are divergently transcribed as a polycistronic
mRNA [6].
In S. aureus, another related mechanism that mediates resistance
to b-lactam antibiotics has been described. It involves the
induction of the low-affinity PBP2a or MecA capable to replace
the inhibited constitutive PBPs [7]. The mecA expression is under
the control of MecI and MecR proteins that are homologous to
S. aureus and B. licheniformis BlaI and BlaR1, and play the same
role. Furthermore, MecI and BlaI from S. aureus are interchange-
able, but BlaR1 and MecR are not [8,9].
The BlaR1 and MecR membrane-bound penicillin-sensory
transducers are composed of two domains, an amino-terminal
domain (BlaR/MecR-NTD) anchored into the cytoplasmic
membrane and a carboxy-terminal domain (BlaR/MecR-CTD)
exposed outside the cell. This latter domain contains in its primary
structure, the conserved motifs of the serine-penicillin recognizing
enzymes (SPRE) and acts as a penicillin sensor [10,11]. The BlaR-
CTD from B. licheniformis and from S. aureus can be produced as
soluble domains and their crystal structures exhibit the conserved
SPRE 3D-fold [12,13,14]. The membrane topology of B.
licheniformis BlaR-NTD (Met
1-Pro
339) has been experimentally
determined: it contains four transmembrane segments (TM1,
TM2, TM3, TM4) connected by three loops named L1 (Lys
27-
Thr
35), L2 (Pro
53-Ser
115) and L3 (Tyr
134-Arg
322). L1 and L3 are
cytoplasmic, whereas L2 is exposed outside the cell (Figure 1) [15].
Although very little is known concerning the mechanism of signal
transduction by BlaR1/MecR, the first step is the acylation of
BlaR/MecR-CTD by the b-lactam antibiotic outside the cell. The
acylation of this domain by the antibiotic causes a modification of
the interaction between BlaR-CTD and L2 and gives rise to the
activation of the L3 cytoplasmic loop via a conformation change of
the four transmembrane segments. The activated L3 would launch
a cytoplasmic signal whose target is BlaI/MecI [10,15,16,17,18].
In this signaling pathway, L2 and the four transmembrane
segments would act as a signal transducer and L3 as a cytoplasmic
signal amplifier. In S. aureus, the BlaR1 L3 activation results in its
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293 and Arg
294 residues [19].
This cleavage site is conserved in B. licheniformis BlaR1 and
partially conserved in S. aureus MecR (Figure 2). In S. aureus, the
activated L3 loop generates a cytoplasmic signal that leads to the
inactivation of the BlaI repressor by proteolysis whereas in B.
licheniformis it has been demonstrated that BlaI is not inactivated by
proteolysis but by the presence of a coactivator coming from
peptidoglycan turnover [20]. Regardless of the route of BlaI
inactivation, activated L3 acts as a protease cleaving either BlaI or
a pro-coactivator [20,21,22]. The hypothesis of L3 protease
activity is supported by the presence within the BlaR1/MecR L3
primary structures, of a HEXXH motif characteristic of the zinc-
binding signature of the neutral zinc metallopeptidases (M4
superfamily) such as thermolysin (Figure 1) [23]. In S. aureus
BlaR1, the mutation of the conserved glutamic acid residue to
alanine gives rise to a non-inducible b-lactamase phenotype [19].
In this paper, we performed site-directed mutagenesis experi-
ments combined with zinc-blot, Western blot and b-lactamase
induction analyses to demonstrate that the cytoplasmic BlaR1 L3
loop belongs to Gluzincin metallopeptidase superfamily and that
its cleavage during BlaR1 activation occurs by self-proteolysis.
Results
L3 Conserved Residues
A multiple sequence alignment of BlaR1/MecR N-terminal
domains of B. licheniformis and S. aureus (Figure 2) revealed 32
strictly conserved residues in the three aligned sequences
corresponding to 9.4% of identity when the length of B. licheniformis
BlaR-NTD sequence is used as reference ([34/339]6100=9.4%).
Out of these 32 conserved residues, 24 are located within the L3
loops ([24/187]6100=12.8%) highlighting the importance of this
conserved loop for intracellular signaling. Conserved residues
include the zinc-binding signature HEXXH of neutral zinc
metalloproteases. Thermolysin is considered as the canonical
enzyme of this protease family, its catalytically essential zinc ion is
coordinated by the two histidine residues of the motif
(H
142EXXH, mature thermolysin numbering), the E
166 and a
water molecule. The catalytic mechanism involves a general base
mechanism including E
143 of the H
142EXXH motif and the
protonated H
231 [24]. Within the strictly conserved residues
present in L3 loop consensus, 4 acidic residues (D: 2 and E: 2)
could play the role of the third zinc ligand or could be involved in
the general base relay. No third conserved histidine residue able to
play the catalytic role of H
231 in thermolysin is present in the L3
loop. The best candidate for this role is a conserved tyrosine
residue (Y
272 in B. licheniformis BlaR-NTD).
Conserved L3 Residues Important for Signal Transduction
or Zn Binding
To highlight if the conserved E, D, H and Y residues are
important for the zinc binding or for the catalytic activity in the
activated L3 loop, the mutants listed in Table 1 were constructed.
The resulting plasmids (pDML1268-78, Table 2) were introduced
into B. subtilis 168 and the recombinant resulting strains tested for
their ability to induce BlaP b-lactamase in presence of the inducer.
In all cases, the mutated receptor expression in non-induced or
induced membranes has been detected by Western blotting
analysis (Figure 3) showing that the introduced mutations do not
lead to the production of an unstable, proteolysis susceptible
receptor.
In order to determine the importance of the HEXXH motif in
L3 activity, alanine scanning mutagenesis was used to generate the
following mutants: H
212A/E
213A/H
216A, E
213A, H
212A/H
216A
Figure 1. Membrane topology of the penicillin-sensory transducer, BlaR1. This receptor contains two domains, an extracellular domain:
BlaR-CTD and a transmembrane domain: BlaR-NTD. BlaR-CTD exhibits the three motifs of the penicillin binding protein family (S*
402TYK, Y
476GN,
K
539TG, where S
402 is the active serine). BlaR-NTD includes four transmembrane segments (TM1, TM2, TM3, TM4) connected by three loops (L1, L2, L3).
The cytoplasmic L3 loop contains the H
212EXXH motif, characteristic to zinc-metalloproteases.
doi:10.1371/journal.pone.0036400.g001
BlaR1 Activation
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216A. Analyses of these mutants indicate that all of these
substitutions give rise to a non-inducible phenotype (Table 1) with
a b-lactamase production similar to that obtained for a non-
induced wild type strain (data not shown).
Neutral Zinc proteases catalyse cleavage of peptide bonds via
a general-base type mechanism in which the glutamate residue
of the conserved motif acts as catalytic base. The mutation of
this glutamate residue to aspartate (E
213D) or to glutamine
Figure 2. Sequence alignment of the amino-terminal domain of the proteins B. licheniformis 749/I BlaR1 (BlBlaR-NTD) and S. aureus
RN4220 BlaR1 (SaBlaR-NTD) and S. aureus MRSA252 MecR (SaMecR-NTD). The conserved residues are highlighted in red and the loop and
transmembrane segments are marked: the transmembrane segments (TM1 to 4) in orange; the extracellular loops B1 (M
1-P
8) and L2 (P
53-S
115)i n
green and the cytoplasmic loops L1 (K
27-T
35) and L3 (Y
134-K
322) in blue. The site of cleavage, situated between the R
293 and R
294 in S. aureus BlaR1, is
indicated by an arrow.
doi:10.1371/journal.pone.0036400.g002
Table 1. Induction of BlaPb-lactamase of the BlaR1 L3 loop mutants.
Mutation Plasmids Induction factor* (3h)
Wild type pDML995 37.861.5
Mutants in H
212EXXH motif H
212A/E
213A/H
216A pDML1268 1.660.1
E
213A pDML1269 1.260.1
H
212A/H
216A pDML1270 1.260.1
H
216A pDML1271 1.2760.01
E
213D pDML1279 1.0760.02
E
213Q pDML1280 1.660.2
Mutants in putative Zn
++ ligands D
221A pDML1277 1.260.1
E
253A pDML1273 1.260.3
D
257A pDML1274 1.960.1
E
274A pDML1275 33.960.9
Mutants in putative general base Y
272A pDML1278 1.160.1
Mutants in R
304R cleavage site R
304A/R
305A pDML3045 7.661.7
*The induction factor corresponds to the ratio between the b-lactamase quantity/A
600 for induced culture and the b-lactamase quantity/A
600 for uninduced culture.
doi:10.1371/journal.pone.0036400.t001
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213Q) prevents b-lactamase induction (Table 1, Figure 3).
These results demonstrate that all the residues of this conserved
motif play an essential role in the induction process.
The sequence alignment of the protein BlaR1 from B.
licheniformis with the proteins BlaR1 and MecR from S. aureus,
highlights four conserved residues that could act as the third
Table 2. Bacterial strains and plasmids used in this study.
Strain or plasmid Relevant characteristic(s) Source
Bacillus licheniformis 749/I b-lactamase inducible strain, wild-type
Bacillus subtilis 168 Recipient cell for E. coli/Bacillus shuttle vectors ATCC 23857
Escherichia coli GI724 Host cell for heterologous expression of BlaR1 L3, F-, lamda-, lacPL8, ampC::Ptrpcl Invitrogen
pUCBM20 Cloning plasmid, Ap
r Boehringer
pCR-Script
TMSK(+) Cloning vector for PCR fragments, Ap
r Stratagene
pLEX Expression vector from inducible P-lambda promoter, Ap
r Novagen
pDML995 A derivative of the Bacillus/E. coli shuttle vector pMK4 [39] carrying the wild-type B. licheniformis 749I
bladivergon, Ap
r in E.coli and Cm
r in Bacillus
A. Brans (unpublished)
pDML1251 pUCBM20 derivative carrying the SstI/EcoRIblaR1 fragment This study
pDML1255 pDML1251 derivative carrying BlaR1H
212A/E
213A/H
216A mutation This study
pDML1256 pDML1251 derivative carrying BlaR1 E
213A mutation This study
pDML1257 pDML1251 derivative carrying BlaR1 H
212A/H
216A mutation This study
pDML1258 pDML1251 derivative carrying BlaR1 H
216A mutation This study
pDML1260 pDML1251 derivative carrying BlaR1 E
253A mutation This study
pDML1261 pDML1251 derivative carrying BlaR1 D
257A mutation This study
pDML1262 pDML1251 derivative carrying BlaR1 E
274A mutation This study
pDML1264 pDML1251 derivative carrying BlaR1 D
221A mutation This study
pDML1265 pDML1251 derivative carrying BlaR1 Y
272A mutation This study
pDML1266 pDML1251 derivative carrying BlaR1 E
213D mutation This study
pDML1267 pDML1251 derivative carrying BlaR1 E
213Q mutation This study
pDML1268 pDML995 derivative carrying BlaR1 H
212A/E
213A/H
216A mutation This study
pDML1269 pDML995 derivative carrying BlaR1 E
213A mutation This study
pDML1270 pDML995 derivative carrying BlaR1 H
212A/H
216A mutation This study
pDML1271 pDML995 derivative carrying BlaR1 H
216A mutation This study
pDML1273 pDML995 derivative carrying BlaR1 E
253A mutation This study
pDML1274 pDML995 derivative carrying BlaR1 D
257Amutation This study
pDML1275 pDML995 derivative carrying BlaR1 E
274A mutation This study
pDML1277 pDML995 derivative carrying BlaR1 D
221A mutation This study
pDML1278 pDML995 derivative carrying BlaR1 Y
272A mutation This study
pDML1279 pDML995 derivative carrying BlaR1 E
213D mutation This study
pDML1280 pDML995 derivative carrying BlaR1 E
213Q mutation This study
pDML3045 pDML995 derivative carrying BlaR1 R
304A/R
305A mutation This study
pDML1283 pCR-ScriptTMSK(+) derivative carrying BlaR1 L3 loop coding sequence This study
pDML1284 pDML1283 derivative carrying BlaR1 L3 E
213A mutation This study
pDML1285 pDML1283 derivative carrying BlaR1 L3 H
212A/H
216A mutation This study
pDML1286 pDML1283 derivative carrying BlaR1 L3 D
257A mutation This study
pDML1287 pDML1283 derivative carrying BlaR1 L3 D
221A mutation This study
pDML1293 pDML1283 derivative carrying BlaR1 L3 E
253A mutation This study
pDML1288 pLEX derivative allowing the expression of BlaR1 L3 loop This study
pDML1289 pLEX derivative allowing the expression of BlaR1 L3 carrying E
213A mutation This study
pDML1290 pLEX derivative allowing the expression of BlaR1 L3 carrying H
212A/H
216A mutation This study
pDML1291 pLEX derivative allowing the expression of BlaR1 L3 carrying D
257A mutation This study
pDML1292 pLEX derivative allowing the expression of BlaR1 L3 carrying D
221A mutation This study
pDML1294 pLEX derivative allowing the expression of BlaR1 L3 carrying E
253A mutation This study
Ap
r: ampicillin resistance.
Cm
r: chloramphenicol resistance.
doi:10.1371/journal.pone.0036400.t002
BlaR1 Activation
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221,E
253,D
257and E
274; see above and Figure 2).
Site-directed mutagenesis of these residues in alanine has been
done and the resulting plasmids carrying these mutations
(pDML1273-74-75-77) were introduced in B. subtilis 168 to
probe the b-lactamase induction (Table 2). The D
221,E
253 and
D
257A mutants show a non-inducible phenotype while the
E
274A mutant retains an inducible phenotype similar to the wild
type receptor (Table 1, Figure 3). This result indicates that E
274
cannot be the third zinc ligand. The three other conserved
residues could play an important role either in the enzymatic
activity, in the Zinc coordination and/or in the folding of
BlaR1 L3 loop. Finally, the mutation of the conserved tyrosine
residue in alanine (Y
272A) also leads to the loss of the b-
lactamase induction (Table 1, Figure 3) suggesting that this
residue could be part of the relay system involved in the acid-
base catalysis.
L3 Overexpression and Zinc-binding Analysis
The DNA sequence coding for the B. licheniformis L3 loop was
introduced into the pLex vector in which l3 was under the
control of the inducible PL promoter from lambda phage. The
resulting plasmid, pDML1288 (Table 2) was introduced in E.
coli GI724. In the induced recombinant strain, the L3 loop was
overproduced as inclusions bodies. After partial purification and
SDS solubilization of inclusion bodies, proteins were separated
by SDS-PAGE (Figure 4 A) and transferred onto a nitrocellu-
lose membrane. The blotted proteins were refolded in presence
of radioactive zinc chloride solution and a specific radioactive
band of 25 kDa was highlighted by autoradiography (Figure 4
B, lane 2). In the utilized technique, it is well accepted that,
after protein refolding, a fraction of enzyme macromolecules are
correctly folded and active. This band is compatible with the
expected molecular mass of L3 (22.116 kDa). The recombinant
strains harboring plasmids with mutated l3 gene encoding for
H
212A/H
216A, E
213A, D
221A, E
253Ao rD
257A (Table 2) has
been also analyzed by Zinc blot analysis after solubilization of
the inclusion bodies (Figure 4 B). As shown in the Figure 4 B,
the H
212A/H
216A, E
253A and D
257A have lost their ability to
bind Zn
++ whereas E
213A and D
221A could be detected as zinc-
binding proteins, highlighting the role of H
212,H
216,E
253A and
D
257 residues in Zn binding.
B. licheniformis L3 is Activated by Autocleavage
To avoid inclusion bodies and/or misfolded proteins due to
overexpression of recombinant membrane protein, the fate of
BlaR1 in presence or not of b-lactam (respectively induced or
uninduced) was carried out by Western blot analysis of B. subtilis-
pDML995 membrane fractions with purified anti-BlaR-CTD
antibodies. These experiments revealed the presence of two
induced bands: a major band of 33 kDa and a minor one of
68 kDa (Figure 5). The band of low molecular mass is compatible
with the cleaved and activated BlaR1 C-terminal domain whereas
the other of high molecular mass should be the full-length
receptor. These results are in agreement with a cleavage of B.
licheniformis BlaR1 between the R
304 and R
305 residues as in the
case of S. aureus BlaR1 cleavage between R
294 and R
295 (Figure 2,
[19]). To confirm these results in B. licheniformis BlaR1, the putative
residues of the cleavage site has been mutated to R
304A/R
305A
and the modified receptor was assayed for its ability to induce BlaP
production. In presence of b-lactam antibiotic, R
304A/R
305A
mutants lightly induces BlaP b-lactamase (IF=7.6, Table 1 and
Figure 5). Furthermore, Western blot analysis of membrane
fractions from non- and induced cells with purified anti-BlaR-
CTD antibodies did not show any L3 cleavage (Figure 6). To
explore if the cleavage of BlaR1 observed in induced B. subtilis/
pDML995 could be the result of L3 proteolytic activity, we
analyzed the fate of BlaR1 HA
213XXH in induced B. subtilis/
pDML1269 membrane fractions by Western blotting as described
above. In this mutant, the catalytic activity of L3 loop is abolished
due to the mutation of the conserved glutamic residue of the
HEXXH motif involved in the neutral Zinc metallopeptidase
family acid-base relay. As shown in Figure 6, no cleavage of BlaR1
HA
213XXH could be detected in presence of the inducer
suggesting that the receptor should be activated via self-proteolysis.
Discussion
Structural studies on thermolysin and homologous enzymes
(Thermolysin-like proteinases, TLPs) have revealed two short
conserved motifs in their active sites: HEXXH and EXXXD [25].
The two histidine residues of the HEXXH sequence serve as
ligands to zinc, whereas the glutamic acid is involved in the
catalytic mechanism by transferring hydrogen atoms and polar-
izing a zinc-bound water molecule for nucleophilic attack on the
Figure 3. Western blot analysis of membrane-bound BlaR1 produced by B. subtilis strains carrying plasmids harboring blaR1
mutants. Membrane proteins from induced (+) or uninduced (-) cultures were separatedon on SDS-PAGE. Purified BlaR-CTD antibodies were used for
the Western blotting. Pre-stained protein molecular weight markers were used (M). The « » pinpoints an intense and non-specific band (for details
see Figure 6). BlaR1 and BlaR1* point out, respectively, the full size and the activated B. licheniformis BlaR1 receptor. Except for mutant E
274A, all other
mutants exhibit non-inducible b-lactamase phenotype. The E
274A mutant has the same profile as the wild-type (to compare see Figure 6). For details
see Tables 1 and 2 and Experimental procedures.
doi:10.1371/journal.pone.0036400.g003
BlaR1 Activation
PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e36400Figure 4. Coomassie Blue-stained SDS-PAGE of partially purified inclusion bodies of wild-type and L3 loop mutants (A) and Zinc
blot analysis (B). In A and B: 1: bovine carbonic anhydrase (AC) (,30 kDa; 5 mg), was used as positive control and 2 to 6 are, respectively, wild type
(WT), E
213A, H
212A/H
216A, D
257 A, D
221 A and E
253 A L3 loop mutants. For each gel 40 mg of inclusion bodies were loaded. The fluorographies were
exposed at -70uC for 72 hours. M: molecular weight marker. The arrow indicates L3 loops.
doi:10.1371/journal.pone.0036400.g004
Figure 5. Induction of b-lactamase synthesis in presence (induced) or not (non-induced) of inducer (2.5 mgm l
21 cephalosporin C)
for the B. subtilis strains transformed with pDML995 (wild-type divergeon;N) or pDML3045 (mutation R
304A/R
305A;#). The level of
the induction is expressed as an induction factor (IF, the ratio between the b-lactamase quantity/A
600 for induced culture and the b-lactamase
quantity/A
600 for uninduced culture).
doi:10.1371/journal.pone.0036400.g005
BlaR1 Activation
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is the glutamic acid residue of the sequence motif EXXXD located
20–60 residues downstream of the second histidine of the first
motif. For this reason, members of thermolysin enzyme family are
named gluzincins [26,27]. The second histidine residue of the
HEXXH motif was found to bridge both the zinc ion and
the carboxylate side chain of the aspartic acid residue within the
second conserved motif. The exact role of this conserved triad, Zn-
His-Asp, is not well understood but is crucial for the catalytic
activity [26,27]. In the absence of a substrate, a water molecule
acts as an additional fourth ligand to zinc and is clamped between
the catalytic glutamic acid residue of the HEXXH motif and the
metal. During TLP catalysis, the catalytic glutamic acid residue
accepts a proton from the zinc-bound water nucleophile and
transfers it to the leaving group of the substrate. Further
stabilization of the transition state is provided by the side-chain
of a conserved histidine residue (H
231 in thermolysin) [28].
Site-directedmutagenesisofselectedconserved residuesinBlaR1/
MecR L3 loops postulated to be involved in catalysis or zinc
chelation, combined with zinc-blot experiments and b-lactamase
induction assay have confirmed all the features present in the active
sites of TLPs. We show that the two histidine residues of the motif
H
212EXXH (B. licheniformis BlaR1 numbering) effectively coordinate
a Zinc ion and are essential for cytoplasmic signalling. The observed
non-inducible b-lactamase phenotype, the conservation of the Zinc
binding capacity and the loss of self-proteolysis exhibited by
H(E
213A)XXH mutant are in agreement with a glutamic acid
residue acting as catalytic residue and a peptidase activity of L3 loop.
The E
253Aa n dD
257A mutants, which exhibited the same non-
inducible phenotype (Table 1), showed that these residues are crucial
for the L3 enzymatic activity and that they are good candidates to be
included inthe second conserved motifof TLPs. In BlaR1/MecRL3
loops, the EXXXD motif is located 37 residues downstream
HEXXH motif, a distance similar to that observed in TLPs, which
varies from 20 residues in thermolysin to 59 in mammalian neutral
endopeptidase. These new observations allow us to classify BlaR1/
MecRL3loops as new members of TLPsor gluzincins.According to
the properties of this enzyme family, the glutamic residue of the
EXXXD motif is the third zinc ligand and the aspartic acid residue
formsacarboxylate-histidine-zincinteractioncrucialforTLPactivity
(see above). Indeed, as shown by 3D structures from several different
enzymes included in the TLP family, this hydrogen bonding
stabilizes the coordination of the zinc ion by one of the histidine
residues of the HEXXH sequence [29]. In rat dipepeptidyl
peptidase, the mutation of the EXXXD motif to EXXXA gives
rise to the loss of the zinc ion and concomitantly the loss of enzyme
activity [26] as it is the case for L3 EXXXA
257 mutant (figure 4 and
Table 1). By analogy, we postulate that the D
257 residue of L3 loop is
involved in zinc binding by orienting the imidazole ring of the H
212
residue and/or by enhancing the basicity of the histidine-zinc ligand.
To complete the zinc-coordination polyhedron, a water molecule, in
interaction with the glutamic acid residue of the HEXXH motif,
should be the fourth zinc ligand.
The conserved residues, D
221 and Y
272 (B. licheniformisBlaR1
numbering) are crucial for the penicillin receptor signalling. The
most likely role for Y
272 is to be involved in the stabilization of
the tetrahedral intermediate complex during the catalysis of the
activated BlaR1/MecR L3 loop. Indeed, carboxypeptidase A,
which shares a common topology with thermolysin for its active site,
possesses anY
248 positioned at the same spatial position of H
231 in
thermolysin [30]. As D
221 side chain is negatively charged, it is
difficult to postulate that this side chain could directly interact with
the negatively charged tetrahedral intermediate. Another hypoth-
esis is that this conserved aspartic acid could be essential for
substrate binding. As our results are consistent with a self-activation
and as the cleavage site includes at least the positively charged side
chain of one arginine residue, this hypothesis is plausible.
Similar to many other proteolytic enzymes, TLPs are synthe-
sized as precursors with a propeptide. Up to 70% of known TLPs
possess a propeptide containing two distinguished domains: the
first one is an intramolecular chaperone (FTP domain) essential for
the folding of the catalytic domain whereas the second one (PepSY
domain) acts as an inhibitor to prevent detrimental TLP activity
[31]. The cleavage of the propeptide occurs through autoproces-
sing and is mediated by the propeptide [26]. In some TLPs, C-
terminal extensions, fused to the Zinc catalytic domain, mediate
their binding to insoluble substrates. These C-terminal extensions
can be autoprocessed and their cleavage modulates the enzyme
specificity and activity [32].
BlaR1/MecR L3 loop activation results in a cascade of events
originated by the acylation of the C-teminal sensor by the
penicillin and finishing by selfproteolysis of the TLP receptor
domain. It has been postulated that the cleavage of the L3 domain
is triggered by a conformational change of the transmembrane
Figure 6. Western blot analysis of membranes of B. subtilis transformed with pMK4 (negative control), pDML995 (wild type),
pDML1269 (E
213A mutant) or pDML3045 (R
304A/R
305A mutant). Membrane proteins from induced (+) or uninduced (2) cultures were
separatedon on SDS-PAGE. Purified BlaR-CTD antibodies were used for the Western blotting. Pre-stained protein molecular weight markers were used
(M). The « » indicates an intense and non-specific band. BlaR1 and BlaR1* highlight, respectively, the full size and the activated B. licheniformis BlaR1
receptor.
doi:10.1371/journal.pone.0036400.g006
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CTD and BlaR/MecR-NTD in presence of penicillin [16]. The
results presented in this paper seem to show that propeptide
inhibiting the BlaR1/MecR TLP domain is present and would be
located at the C-terminal end of TLP domain. The cleavage site
should be included in the K
303(E/R)QR conserved motif
(Figure 2), in which ‘‘Q’’ indicates the cleaved peptide bond,
instead of R
304QR motif as previously described [19]. The
presence of a C-terminal propeptide inhibiting L3 TLP activity
and cleaved by self-proteolysis to give the fully active L3 TLP
would be unique to BlaR1/MecR in the TLP superfamily.
The RR/AA cleavage site mutant also sheds new light on the
BlaR1/MecR intramolecular transduction mechanism. Indeed, in
presence of b-lactam antibiotic, the acylation of the mutated
BlaR1 receptor results in a slight induction of BlaP b-lactamase
production (about 20% of the wild type) but without L3 cleavage.
In the uncleaved protein, the C-terminal portion of the L3 loop
acts as an inhibitor of its TLP domain. Cleavage of the KRQR
(both BlaR1 proteins) or KEQR( S. aureusMecR) results in an
activation of the peptidase activity, but it is not known whether the
C-terminal peptide remains associated or not with the active
domain. In fact, in this mutant, we have decoupled the L3
activation due to BlaR-CTD acylation from that caused by L3
selfproteolysis. The BlaP induction results indicate that in this case,
the uncleaved L3 loop exhibits a residual activity which seems
unable to perform a successful autocleavage but is able to produce
a sufficient amount of coactivator to partially inactivate BlaI. This
finding is in agreement with a selfproteolysis mechanism in which
it is necessary that BlaR-CTD acylation slightly activates L3 loop
to allow its own proteolysis and its full activation.
In conclusion BlaR1/MecR L3 loop is a gluzincin and a new
member of the TLP superfamily that has diverged very early from
canonical TLPs, since no significant identity can be detected
between BlaR1/MecR L3 loops and TLPs by using comparison
algorithms such as BLAST. The L3 signalling activity of BlaR1/
MecR receptor would be repressed by the combination of two
intramolecular interactions: one between L3 and its C-terminal
propeptide and the second between L2 and BlaR-CTD. Similarly
the full L3 activation triggered BlaR-CTD acylation would be the
consequence of two successive events described above.
Materials and Methods
Bacterial Strains, Plasmids and DNA Manipulations
The strains and plasmids used in this study are described in
Table 2. To introduce point mutations into BlaR1 or L3 loop,
mutagenesis was carried out using the Quick Change Site-
Directed mutagenesis procedure (Stratagene). For all mutations,
except BlaR1 R
304A/R
305A mutation, the plasmids pDML1251
and 1283 were used as the templates in polymerase chain reactions
(PCR) for blaR1 and l3 loop site-directed mutagenesis, respectively.
For BlaR1 R
304A/R
305A mutation, pDML995 was used as
template. Synthetic oligonucleotides 23–35 bases long containing
a mutated codon in the middle of their sequences (Table 3) were
employed to mutagenize the original codons. Following the
verification of mutations by DNA sequencing (GIGA-DNA
sequencing plateform, University of Lie `ge), the corresponding
restricted fragments (blaR1: 672 bp SstI-EcoRI; l3 loop: 567 bp
NdeI-SalI) were cloned into pDML995 and pLex, respectively.
All routine DNA isolation and manipulation were performed as
described by Sambrook et al. [33] or following instructions of the
manufacturer. Restriction enzymes and mini-prep kit to prepare
small-scale plasmid DNA were purchased from Promega and
Fermentas respectively.
Overexpression of B. licheniformis BlaR1 L3 Loop and
Purification of Inclusion Bodies
The coding sequence corresponding to B. licheniformis BlaR1 L3
loop (residues Tyr
134 to Arg
322) was amplified by PCR from
pDML995 plasmid and with KBJ1 and KBJ2 primers (Table 3)
containing respectively restriction sites, NdeI and SalI at their 59-
ends. The resulting fragment (567 bp) was cloned into pCR-Script
to give pDML1283 plasmid. After purification of the resulting
plasmid and the sequencing of the insert to verify its integrity, the
plasmid was digested with NdeI and SalI and the fragment
corresponding to the B. licheniformis BlaR1 L3 loop was ligated into
the pLex vector digested with the same restriction endonucleases
to give pDML1288. The pDML1289-94 plasmids are pDML1288
derivatives carrying respectively the mutation E
213A, H
212H/
H
216H, E
253A, D
257Ao rD
221A (Table 2). These mutations were
introduced as described above.
The E. coli GI724/pDML1288-94 strains were grown over
night at 30uC in RM medium (40 mM Na2HPO4, 20 mM
KH2PO4, 10 mM NaCl, 200 mM NH4Cl, 2% casamino acids,
1% glycerol, 1 mM MgCl2, 100 mgm l
21 ampicillin). The culture
was then diluted 100 times in IM medium (40 mM Na2HPO4,
20 mM KH2PO4, 10 mMNaCl, 200 mM NH4Cl, 2% casamino
acids, 0.5% glucose, 1 mM MgCl2, 100 mgm l
21 ampicilline) and
cultivated at 30uC. When the absorbance at 550 nm reached 0.6,
L3 loop expression was induced by both the addition of
tryptophan (final concentration: 100 mgm l
21) and a temperature
shift to 37uC. After 3 hours of induction, the cells were harvested
by centrifugation, washed with 50 mM HEPES-NaOH (pH 7.5)
and suspended in 50 mM Tris-HCl (pH 7.5). Bacterial cells were
disrupted using a Basic Z Model disintegrator (Warwick, UK).
After the addition of Benzonase (final concentration: 20 mgm l
21)
and an incubation of 30 min at 4uC, the insoluble cell fraction
containing inclusion bodies, was separated from the soluble
fraction by centrifugation at 18000 g for 30 min at 4uC. The
insoluble fraction was suspended in 50 mM HEPES-NaOH
(pH 7.5), 0.5 mM NaCl, 5 mM DTT. After addition of Triton
X100 (final concentration: 0.1%), the suspension was incubated
under agitation at room temperature for 1 hour. The inclusion
bodies containing the L3 loop were recovered by centrifugation at
18000 g, for 30 min and at 4uC.
Zinc Binding Assay
Soluble or insoluble Zinc binding proteins were detected by
Zinc blot assay [34,35,36]. Purified inclusion bodies were
solubilized by sodium dodecyl sulfate (SDS, solubilization buffer:
Tris-HCl 0.5M pH 6.8) and separated by SDS-PAGE. After
electrophoresis, the gel was soaked for one hour at 37uCi n2 5m M
Tris-HCl (pH 8.3), 190 mM glycine, 0.1% SDS, 5% 2-b-
Mercaptoe ´thanol. The proteins were electrophoretically trans-
ferred to a nitrocellulose membrane in 25 mM Tris-HCl (pH 8.3),
190 mM glycine, 0.1% SDS, 20% methanol.
The nitrocellulose membrane was first incubated for 1 hour at
room temperature in 10 mM Tris-HCl (pH 7.5) to partially
renature blotted proteins. The membrane was then soaked two
times, 15 min per soaking, in 50 ml of binding buffer (10 mM
Tris-HCl (pH 7.5), 0.1 M KCl) containing 1mCi
65ZnCl and
washed 30 minutes with two changes of binding buffer. The blot
was dried one hour at room temperature and analyzed by
autoradiography using X-OMAT
TM film (Eastman Kodak Com-
pany) and an exposure time of 72 hours at 270uC.
b-lactamase Induction Assay
Bacillus subtilis 168 transformed by pDML995 or derivative
plasmids was grown at 37uC in Luria-Bertani (LB) medium
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21 of chloramphenicol until A
600 reached 0.2.
Then, the culture is divided in two portions, one as a control (non
induced cells) and the other for the addition of 5 mgm l
21
cephalosporin C (induced cells). In these conditions the concen-
tration of inducer is below its minimal inhibitory concentration: 10
and 20 mgm l
21, respectively, for B. subtilis recombinant strains
exhibiting non- and inducible b-lactamase phenotype (Ana
Amoroso, unpublished data).
The incubation was continued and samples were withdrawn at
hourly intervals for 6 hours. For each sample, the A
600 was
measured to monitor the cell density as well as the b-lactamase
activity. This latter activity was spectrophotometrically determined
by using nitrocefin as previously describred [17]. The b-lactamase
quantity by cell [Et] was calculated by using the following equation:
v0/(cellular density) = DA
482/(Dt. e.A
600)=( k cat 6[Et] 6[S])/
(Km + [S]) were v0: the initial velocity; DA
482and Dt are absorbance
and time variations, respectively; kcat: catalytic constant (470 s
21)
[37]; [S]:substrateconcentration(100 mM); Km:40 mM [37] ande:
nitrocefin coefficient of molar extinction at 482 nm
(15000 M
21 cm
21). The b-lactamase induction level was expressed
as ‘‘induction factor’’ (IF), determined as: FI= ([Et] of induced
culture)/([Et] of uninduced culture).
Anti-BlaR-CTD Antibodies Production and Western
Blotting
A polyclonal antiserum directed against the BlaR1 sensor (BlaR-
CTD), was generated by immunizing New Zealand rabbits with
purified BlaR-CTD [17]. Polyclonal antibodies were purified
against BlaR-CTD immobilized on Sepharose 4B as described in
reference [38]. The purified primary antibodies were used in
immunoblotting at a final dilution of 1:1000.
Ten milliliters of induced or uninduced recombinant B. subtilis
strains were harvested by centrifugation and resuspended in 200 ml
of 50 mM Tris-HCl (pH 7.5). Cells were disrupted by sonication
in a Branson ultrasonic disintegrator at amplitude of 6 mm for tree
30 s bursts. Membranes fraction, containing the BlaR1 receptor
were obtained as insoluble fraction by centrifugation of the lysates.
Membrane proteins were solubilized by SDS (solubilization buffer:
Tris-HCl 0.5 M pH 6.8) and separated by SDS-PAGE (15%
acrylamide) and transferred onto a nitrocellulose membrane
(Millipore). Incubation of the membrane with primary antibodies
was followed by incubation with alkaline phosphatase-conjugated
anti-rabbit antibodies. The immune complexes were detected by a
color reaction with nitroblue tetrazolium and 5-bromo-4-chloro-3-
indoyl phosphate, as recommended by the manufacturer (Roche
Applied Science).
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Table 3. Oligonucleotides used in this study.
Name Nucleotide sequence Utilities
L3up 59-TAACATATGGATCCTAGCAATCTAAAAATCGGC-39 L3 loop sequence
L3rp 59-AAGCTTGTCGACTTATTTCGCCTTTAGCAAAGGTG-39 amplification
E213Aup 59-GCTTCATGCACTGTACCATTGCAAAC-39 Mutation
E213Arp 59-GTTTGCAATGGTACAGTGCATGAAGC-39 E
213A
H212AH216Aup 59-GAAATGTGTTTTGCTTGCTGAACTGTACGCTTGC-39 Mutation
H212AH216Arp 59-GCAAGCGTACAGTTCAGCAAGCAAAACACATTTC-39 H
212A/H
216A
H212AE213AH216Aup 59-GCTTGCTGCACTGTACGCTTGCCAAACG-39 Mutation
H212AE213AH216Arp 59-CGTTTGGCAAGCGTACAGTGCAGCAAGC-39 H
212A/E
213A/H
212A
E253Aup 59-CGAAAACGGAGATGGCGATTTCTTGC-39 Mutation
E253Arp 59-GCAAGAAATCGCCATCTCCGTTTTCG -39 E
253A
D257Aup 59-GATTTCTTGCGCCTTTGCCGTATTAAAAAC-39 Mutation
D257Arp 59-GTTTTTAATACGGCAAAGGCGCAAGAAATC-39 D
257A
D221Aup 59-GCAAACGAAAAGCCATGCTTATCAAC-39 Mutation
D221Arp 59-GTTGATAAGCATGGCTTTTCGTTTGC-39 D
221A
Y272Aup 59-GCACCTCAAAGCTGGCGAGGTG-39 Mutation
Y272Arp 59-CACCTCGCCAGCTTTGAGGTGC-39 Y
272A
E274Aup 59-CCTCAAATATGGCGCGGTGATTTTAAAATTCAC-39 Mutation
E274Arp 59-GTGAATTTTAAAATCACCGCGCCATATTTGAGG-39 E
274A
E213Qup 59-GTTTTGCTTCATCAGCTGTACCATTGC-39 Mutation
E213Qrp 59-GCAATGGTACAGCTGATGAAGCAAAAC-39 E
213Q
E213Dup 59-GTTTTGCTTCATGACCTGTACCATTGC-39 Mutation
E213Drp 59-GCAAATGGTACAGGTCATGAAGCAAAAC-3’ E
213D
R304AR305Aup 5’-TACAAACATATCAAAGCAGCGATTGTTACAGTTGTCAAC-3’ Mutation
R304AR305Arp 5’-GTTGACAACTGTAACAATCGCTGCTTTGATATGTTTGTA-3’ R
304A/R
305A
Modified codons are underlined and mutagenised bases are highlighted.
doi:10.1371/journal.pone.0036400.t003
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